GENOVIS AB has a total of 103 patent applications. It increased the IP activity by 66.0%. Its first patent ever was published in 1999. It filed its patents most often in EPO (European Patent Office), Australia and Canada. Its main competitors in its focus markets biotechnology, measurement and foods and drinks are HYGLOS INVEST GMBH, AELAN CELL TECH INC and HENAN CELNOVTEBIO BIOTECHNOLOGY INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 12 | |
#2 | Australia | 11 | |
#3 | Canada | 11 | |
#4 | WIPO (World Intellectual Property Organization) | 11 | |
#5 | Republic of Korea | 9 | |
#6 | United Kingdom | 8 | |
#7 | United States | 8 | |
#8 | China | 7 | |
#9 | Israel | 5 | |
#10 | Singapore | 5 | |
#11 | Brazil | 4 | |
#12 | Sweden | 3 | |
#13 | Norway | 2 | |
#14 | EAPO (Eurasian Patent Organization) | 1 | |
#15 | Hong Kong | 1 | |
#16 | India | 1 | |
#17 | Mexico | 1 | |
#18 | New Zealand | 1 | |
#19 | Poland | 1 | |
#20 | South Africa | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Measurement | |
#3 | Foods and drinks | |
#4 | Medical technology | |
#5 | Pharmaceuticals | |
#6 | Micro-structure and nano-technology |
# | Technology | |
---|---|---|
#1 | Microorganisms | |
#2 | Analysing materials | |
#3 | Enzymes | |
#4 | Measuring microorganism processes | |
#5 | Peptides | |
#6 | Electrotherapy | |
#7 | Fermentation | |
#8 | Microbiology | |
#9 | Medical preparations | |
#10 | Nanostructure applications |
# | Name | Total Patents |
---|---|---|
#1 | Fredriksson Sarah | 53 |
#2 | Olsson Fredrik | 47 |
#3 | Mejare Malin | 23 |
#4 | Kriz Dario | 21 |
#5 | Bjork Stephan | 16 |
#6 | Leo Fredrik | 16 |
#7 | Lood Rolf | 16 |
#8 | Allhorn Maria | 15 |
#9 | Collin Mattias | 15 |
#10 | Nordgren Maria | 14 |
Publication | Filing date | Title |
---|---|---|
CA3063828A1 | Enzymes for glycan analysis | |
GB201806655D0 | Polypeptide | |
GB201708471D0 | Polypeptide | |
GB201708476D0 | Tools for glycan analysis | |
SG11201806639VA | New streptococcal proteases | |
GB201416849D0 | Method | |
GB201318490D0 | Method | |
GB201316744D0 | Method | |
GB201115841D0 | Protein and method | |
CN101889082A | Method and kits for dissociating Fcgamma-receptor-IgG complexes and for igg purification and detection | |
EP1940513A1 | A nanoparticle suitable for delivery of a biomolecule into or out of a membrane enclosed cell or cell organelle | |
BR0314214A | Magnetically induced membrane transport particle | |
AU2003245198A1 | Device for multiple simultaneous gene transfer | |
BR0013882A | Device for introducing pores into biological materials |